View Cart  

Quality Compliance Concerns Land DePuy a Warning Letter

The FDA slapped Johnson & Johnson’s DePuy Orthopaedics with a warning letter citing quality system compliance concerns at its Warsaw, Ind., plant, including lack of proper design validation procedures.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00